JP2011506400A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011506400A5 JP2011506400A5 JP2010537456A JP2010537456A JP2011506400A5 JP 2011506400 A5 JP2011506400 A5 JP 2011506400A5 JP 2010537456 A JP2010537456 A JP 2010537456A JP 2010537456 A JP2010537456 A JP 2010537456A JP 2011506400 A5 JP2011506400 A5 JP 2011506400A5
- Authority
- JP
- Japan
- Prior art keywords
- drug substance
- suspension
- solvent
- drug
- high pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940088679 drug related substance Drugs 0.000 description 13
- 239000008186 active pharmaceutical agent Substances 0.000 description 12
- 239000000725 suspension Substances 0.000 description 7
- 239000002245 particle Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 238000000265 homogenisation Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229940015042 glycopyrrolate Drugs 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000012296 anti-solvent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- -1 it after drying Substances 0.000 description 1
- 238000010902 jet-milling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07123165 | 2007-12-13 | ||
| PCT/EP2008/067364 WO2009074666A1 (en) | 2007-12-13 | 2008-12-11 | Organic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011506400A JP2011506400A (ja) | 2011-03-03 |
| JP2011506400A5 true JP2011506400A5 (OSRAM) | 2012-02-16 |
Family
ID=39387173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010537456A Pending JP2011506400A (ja) | 2007-12-13 | 2008-12-11 | 有機化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100266696A1 (OSRAM) |
| EP (1) | EP2229148B1 (OSRAM) |
| JP (1) | JP2011506400A (OSRAM) |
| KR (1) | KR20100095587A (OSRAM) |
| CN (1) | CN101896165B (OSRAM) |
| AU (1) | AU2008334547B2 (OSRAM) |
| BR (1) | BRPI0820745A2 (OSRAM) |
| CA (1) | CA2707594C (OSRAM) |
| ES (1) | ES2460576T3 (OSRAM) |
| PL (1) | PL2229148T3 (OSRAM) |
| PT (1) | PT2229148E (OSRAM) |
| RU (1) | RU2496479C2 (OSRAM) |
| WO (1) | WO2009074666A1 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107595771A (zh) | 2010-10-18 | 2018-01-19 | 大日本住友制药株式会社 | 注射用缓释制剂 |
| BR112013027391A2 (pt) * | 2011-05-03 | 2017-01-17 | Chiesi Farmaceutic S P A | formulação farmacêutica, frasco e kit |
| US9393202B2 (en) | 2013-04-26 | 2016-07-19 | Chiesi Farmaceutici S.P.A | Particle size reduction of an antimuscarinic compound |
| GB201307659D0 (en) | 2013-04-26 | 2013-06-12 | Korea Coast Guard Commissioner | Preparation of drug particles by micronisation |
| PT107433B (pt) * | 2014-01-28 | 2018-12-04 | Hovione Farm S A | Processo de redução e controlo do tamanho de partícula |
| KR101927960B1 (ko) | 2014-09-09 | 2018-12-11 | 벡투라 리미티드 | 글리코피롤레이트를 포함하는 제형, 방법 및 장치 |
| CN106749008A (zh) * | 2015-11-23 | 2017-05-31 | 北京九和药业有限公司 | 一种马来酸茚达特罗的微粉化方法及其应用 |
| PT109030B (pt) | 2015-12-15 | 2019-09-25 | Hovione Farmaciência, S.A. | Preparação de partículas inaláveis de zafirlucaste |
| US9925168B2 (en) * | 2016-01-22 | 2018-03-27 | Chiesi Farmaceutici S.P.A. | Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation |
| US10888500B2 (en) | 2016-07-29 | 2021-01-12 | Inke, S.A. | Particle size stabilization process |
| CN112137957B (zh) * | 2019-06-26 | 2022-07-29 | 长风药业股份有限公司 | 一种药用吸入气雾剂及其制备方法 |
| WO2021216577A1 (en) * | 2020-04-20 | 2021-10-28 | Board Of Regents, The University Of Texas System | Lipid nanoparticle (lnp) delivery systems and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
| IT1303692B1 (it) * | 1998-11-03 | 2001-02-23 | Chiesi Farma Spa | Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione. |
| GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| GB0016040D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
| EP1920763B2 (en) * | 2000-11-30 | 2022-06-15 | Vectura Limited | Pharmaceutical compositions for inhalation |
| ITMI20020681A1 (it) * | 2002-03-29 | 2003-09-29 | Acs Dobfar Spa | Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina |
| ITMI20022674A1 (it) * | 2002-12-18 | 2004-06-19 | Chiesi Farma Spa | Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione. |
| EP1729729B1 (en) * | 2004-03-23 | 2014-04-23 | Novartis AG | Pharmaceutical compositions |
| GB0409703D0 (en) * | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
| EP1834624A4 (en) | 2005-01-07 | 2011-05-04 | Eisai R&D Man Co Ltd | MEDICAL COMPOSITION AND MANUFACTURING METHOD THEREFOR |
| CA2603433A1 (en) * | 2005-03-30 | 2006-10-05 | Schering Corporation | Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist |
| KR20080038178A (ko) * | 2005-08-26 | 2008-05-02 | 아스트라제네카 아베 | 호흡기 질환, 특히 만성 폐쇄성 폐 질환 (ｃｏｐｄ) 및천식의 치료에 사용할 수 있는 화합물들의 조합물 |
| US8530463B2 (en) * | 2007-05-07 | 2013-09-10 | Hale Biopharma Ventures Llc | Multimodal particulate formulations |
-
2008
- 2008-12-11 PL PL08859412T patent/PL2229148T3/pl unknown
- 2008-12-11 JP JP2010537456A patent/JP2011506400A/ja active Pending
- 2008-12-11 RU RU2010128248/15A patent/RU2496479C2/ru not_active IP Right Cessation
- 2008-12-11 AU AU2008334547A patent/AU2008334547B2/en not_active Ceased
- 2008-12-11 KR KR1020107012911A patent/KR20100095587A/ko not_active Ceased
- 2008-12-11 WO PCT/EP2008/067364 patent/WO2009074666A1/en not_active Ceased
- 2008-12-11 PT PT88594122T patent/PT2229148E/pt unknown
- 2008-12-11 US US12/745,806 patent/US20100266696A1/en not_active Abandoned
- 2008-12-11 BR BRPI0820745-3A patent/BRPI0820745A2/pt not_active IP Right Cessation
- 2008-12-11 CA CA2707594A patent/CA2707594C/en not_active Expired - Fee Related
- 2008-12-11 EP EP08859412.2A patent/EP2229148B1/en not_active Revoked
- 2008-12-11 CN CN2008801205834A patent/CN101896165B/zh not_active Expired - Fee Related
- 2008-12-11 ES ES08859412.2T patent/ES2460576T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011506400A5 (OSRAM) | ||
| Salústio et al. | The influence of the preparation methods on the inclusion of model drugs in a β-cyclodextrin cavity | |
| Raimi-Abraham et al. | Development and characterization of amorphous nanofiber drug dispersions prepared using pressurized gyration | |
| CN102228430B (zh) | 水飞蓟宾磷脂复合物的纳米混悬剂及其制备方法 | |
| WO2014161131A1 (en) | PREPARING AMORPHOUS MELOXICAM-β-CYCLODEXTRIN INCLUSION COMPLEX VIA SPRAY DRYING PROCESS | |
| Xie et al. | Novel redispersible nanosuspensions stabilized by co-processed nanocrystalline cellulose–sodium carboxymethyl starch for enhancing dissolution and oral bioavailability of baicalin | |
| US20120231093A1 (en) | Method for preparing nano-scale or amorphous particle using solid fat as a solvent | |
| JP2010526848A (ja) | 難溶性薬物用の医薬組成物 | |
| Ueda et al. | Equilibrium state at supersaturated drug concentration achieved by hydroxypropyl methylcellulose acetate succinate: Molecular characterization using 1H NMR technique | |
| Zhang et al. | Nanonization of megestrol acetate by liquid precipitation | |
| US11318115B2 (en) | Oral pharmaceutical composition of Tecovirimat and preparation method thereof | |
| Pas et al. | Preparation of amorphous solid dispersions by cryomilling: chemical and physical concerns related to active pharmaceutical ingredients and carriers | |
| Deshpande et al. | Supercritical fluid technology: concepts and pharmaceutical applications | |
| Kalpana et al. | Solid Dispersion: Approaches, Technology involved, Unmet need & Challenges. | |
| CN102871950B (zh) | 一种熊果酸固体分散体及其制备方法 | |
| JP2023040147A (ja) | インジルビン及びその誘導体を含有する新規の医薬製剤並びにその製造方法及び使用方法 | |
| JP2019521147A (ja) | 注射のためのテコビリマットの医薬組成物およびその調製方法 | |
| Tierney et al. | Carrier particle design for stabilization and isolation of drug nanoparticles | |
| Ajinkya et al. | Scaffold based drug delivery system: A special emphasis on nanosponges | |
| Mehta et al. | Improving solubility of BCS class II drugs using solid dispersion | |
| Makarem et al. | Electro-organic synthesis of nanosized particles of 2-amino-pyranes | |
| Nep et al. | Evaluation of grewia polysaccharide gum as a suspending agent | |
| Liu et al. | Preparation nanocrystals of poorly soluble plant compounds using an ultra-small-scale approach | |
| CN105688223B (zh) | 一种小粒径微晶纤维素丸芯的制备工艺 | |
| Bhirud et al. | Advances in solid dispersion technology and its applications in the development of solid dosage forms |